The importance of matrix metalloproteinase-3 in respiratory disorders
暂无分享,去创建一个
[1] M. Balaan,et al. Acute Respiratory Distress Syndrome , 2016, Critical care nursing quarterly.
[2] V. Ranieri,et al. Novel approaches to minimize ventilator-induced lung injury , 2015, Current opinion in critical care.
[3] Kyung-Ja Cho,et al. Epithelial-Mesenchymal Transition , 2014, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[4] D. Thickett,et al. Epithelial–mesenchymal transition in lung development and disease: does it exist and is it important? , 2013, Thorax.
[5] K. Rabe,et al. Management of non-small-cell lung cancer: recent developments , 2013, The Lancet.
[6] R. Khokha,et al. Metalloproteinases and their natural inhibitors in inflammation and immunity , 2013, Nature Reviews Immunology.
[7] A. Ciapponi,et al. High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult patients with acute lung injury and acute respiratory distress syndrome. , 2013, The Cochrane database of systematic reviews.
[8] Maria João M Bugalho,et al. RAC1b overexpression in papillary thyroid carcinoma: a role to unravel. , 2013, European journal of endocrinology.
[9] Anthony J Alberg,et al. Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. , 2013, Chest.
[10] Brent S. Pedersen,et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis , 2013, Nature Genetics.
[11] D. Radisky,et al. Matrix compliance regulates Rac1b localization, NADPH oxidase assembly, and epithelial–mesenchymal transition , 2012, Molecular biology of the cell.
[12] G. Downey,et al. IL‐1β enhances cell adhesion to degraded fibronectin , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[13] D. Radisky,et al. Matrix Metalloproteinase Induction of Rac1b, a Key Effector of Lung Cancer Progression , 2012, Science Translational Medicine.
[14] D. Radisky,et al. Involvement of hnRNP A1 in the matrix metalloprotease‐3‐dependent regulation of Rac1 pre‐mRNA splicing , 2012, Journal of cellular biochemistry.
[15] Arthur S Slutsky,et al. Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .
[16] T. Maher. Idiopathic pulmonary fibrosis: pathobiology of novel approaches to treatment. , 2012, Clinics in chest medicine.
[17] Xue-qing Xu,et al. Association between Polymorphisms in the Promoter Regions of Matrix Metalloproteinases (MMPs) and Risk of Cancer Metastasis: A Meta-Analysis , 2012, PloS one.
[18] Moisés Selman,et al. Idiopathic pulmonary fibrosis , 2011, The Lancet.
[19] Michael J. Cronce,et al. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition , 2011, Proceedings of the National Academy of Sciences.
[20] D. Radisky,et al. Cardiovascular , Pulmonary , and Renal Pathology Matrix Metalloproteinase 3 Is a Mediator of Pulmonary Fibrosis , 2011 .
[21] G. Downey. Resolving the scar of pulmonary fibrosis. , 2011, The New England journal of medicine.
[22] Thomas A. Wynn,et al. Integrating mechanisms of pulmonary fibrosis , 2011, The Journal of experimental medicine.
[23] R. D. du Bois,et al. Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium. , 2011, Chest.
[24] Ivana V. Yang,et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. , 2011, The New England journal of medicine.
[25] C. Owen,et al. Matrix metalloproteinases: all the RAGE in the acute respiratory distress syndrome. , 2011, American journal of physiology. Lung cellular and molecular physiology.
[26] M. Matthay,et al. Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells. , 2011, American journal of physiology. Lung cellular and molecular physiology.
[27] Takeshi Johkoh,et al. American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .
[28] P. Lansdorp,et al. Ancestral Mutation in Telomerase Causes Defects in Repeat Addition Processivity and Manifests As Familial Pulmonary Fibrosis , 2011, PLoS genetics.
[29] M. Matthay,et al. The acute respiratory distress syndrome: pathogenesis and treatment. , 2011, Annual review of pathology.
[30] Ingebrigt Sylte,et al. Regulation of matrix metalloproteinase activity in health and disease , 2011, The FEBS journal.
[31] X. Puente,et al. Absence or inhibition of matrix metalloproteinase-8 decreases ventilator-induced lung injury. , 2010, American journal of respiratory cell and molecular biology.
[32] G. Downey,et al. Importance of Protein-tyrosine Phosphatase-α Catalytic Domains for Interactions with SHP-2 and Interleukin-1-induced Matrix Metalloproteinase-3 Expression* , 2010, The Journal of Biological Chemistry.
[33] D. Radisky,et al. The 19-Amino Acid Insertion in the Tumor-associated Splice Isoform Rac1b Confers Specific Binding to p120 Catenin* , 2010, The Journal of Biological Chemistry.
[34] Matthias Briel,et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. , 2010, JAMA.
[35] E. White,et al. Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis. , 2010, American journal of respiratory and critical care medicine.
[36] G. Perkins,et al. Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome , 2009, Critical care medicine.
[37] W. Seeger,et al. WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. , 2009, The Journal of clinical investigation.
[38] D. Radisky,et al. Change in cell shape is required for matrix metalloproteinase‐induced epithelial‐mesenchymal transition of mammary epithelial cells , 2008, Journal of cellular biochemistry.
[39] Robert A. Weinberg,et al. Twisted epithelial–mesenchymal transition blocks senescence , 2008, Nature Cell Biology.
[40] W. Seeger,et al. Functional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis , 2008, PloS one.
[41] Ping Yang,et al. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. , 2008, Mayo Clinic proceedings.
[42] D. Radisky,et al. Matrix metalloproteinase-induced fibrosis and malignancy in breast and lung. , 2008, Proceedings of the American Thoracic Society.
[43] Naftali Kaminski,et al. MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis , 2008, PLoS medicine.
[44] A. Gutiérrez-Fernández,et al. Lack of matrix metalloproteinase-9 worsens ventilator-induced lung injury. , 2008, American Journal of Physiology - Lung cellular and Molecular Physiology.
[45] N. Kaminski,et al. Idiopathic Pulmonary Fibrosis: Aberrant Recapitulation of Developmental Programs? , 2008, PLoS medicine.
[46] S. Jaber,et al. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. , 2008, JAMA.
[47] K. Kuwano,et al. Dual-immunohistochemistry provides little evidence for epithelial–mesenchymal transition in pulmonary fibrosis , 2008, Histochemistry and Cell Biology.
[48] C. Libert,et al. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation , 2007, Journal of leukocyte biology.
[49] J. Varani,et al. Matrix metalloproteinase-3 (stromelysin-1) in acute inflammatory tissue injury. , 2007, Experimental and molecular pathology.
[50] Chao Xing,et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase , 2007, Proceedings of the National Academy of Sciences.
[51] P. Lansdorp,et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. , 2007, The New England journal of medicine.
[52] Andrew J. Ewald,et al. Matrix metalloproteinases and the regulation of tissue remodelling , 2007, Nature Reviews Molecular Cell Biology.
[53] S. Gayther,et al. Molecular profiling of cervical cancer progression , 2007, British Journal of Cancer.
[54] Changqing Zeng,et al. Haplotypes in Matrix Metalloproteinase Gene Cluster on Chromosome 11q22 Contribute to the Risk of Lung Cancer Development and Progression , 2006, Clinical Cancer Research.
[55] A. Lièvre,et al. Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma , 2006, BMC Cancer.
[56] G. Oster,et al. Incidence and prevalence of idiopathic pulmonary fibrosis. , 2006, American journal of respiratory and critical care medicine.
[57] Gordon R Bernard,et al. Comparison of two fluid-management strategies in acute lung injury. , 2006, The New England journal of medicine.
[58] J. Keski‐Oja,et al. Epilysin (MMP-28) induces TGF-β mediated epithelial to mesenchymal transition in lung carcinoma cells , 2006, Journal of Cell Science.
[59] D. Brenner,et al. Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis , 2006, Hepatology.
[60] T. Standiford,et al. Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury. , 2006, Human pathology.
[61] J. Minna,et al. Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines. , 2006, Cancer research.
[62] G. Cavet,et al. Epithelial versus Mesenchymal Phenotype Determines In vitro Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients , 2005, Clinical Cancer Research.
[63] E. Brown,et al. Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. , 2005, Cancer research.
[64] R. Veldhuizen,et al. Differential response of TIMP-3 null mice to the lung insults of sepsis, mechanical ventilation, and hyperoxia. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[65] D. Albertson,et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability , 2005, Nature.
[66] W. Guo,et al. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. , 2004, Carcinogenesis.
[67] Radovan Dvorsky,et al. Alternative Splicing of Rac1 Generates Rac1b, a Self-activating GTPase* , 2004, Journal of Biological Chemistry.
[68] Arthur S Slutsky,et al. Biotrauma hypothesis of ventilator-induced lung injury. , 2004, American journal of respiratory and critical care medicine.
[69] John G. Collard,et al. Tumor-related Alternatively Spliced Rac1b Is Not Regulated by Rho-GDP Dissociation Inhibitors and Exhibits Selective Downstream Signaling* , 2003, Journal of Biological Chemistry.
[70] S. Chakraborti,et al. Regulation of matrix metalloproteinases: An overview , 2003, Molecular and Cellular Biochemistry.
[71] J. Mullol,et al. Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.
[72] W. Parks,et al. Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. , 2003, The American journal of pathology.
[73] V. Lagente,et al. Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients , 2003, Critical care medicine.
[74] Naftali Kaminski,et al. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[75] B. Fingleton,et al. Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.
[76] L. Van Aelst,et al. The role of Rho GTPases in disease development. , 2002, Gene.
[77] E. Sahai,et al. RHO–GTPases and cancer , 2002, Nature Reviews Cancer.
[78] John G. Collard,et al. Regulation of the cytoskeleton by Rho-family GTPases: implications for tumour cell invasion. , 2001, Seminars in cancer biology.
[79] D. Bar-Sagi,et al. Ras and Rho GTPases A Family Reunion , 2000, Cell.
[80] E. Lengyel,et al. Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b , 2000, Oncogene.
[81] D. Schoenfeld,et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.
[82] J. Foidart,et al. Demonstration in vivo that stromelysin-3 functions through its proteolytic activity , 2000, Oncogene.
[83] B. Fingleton,et al. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. , 2000, The Journal of clinical investigation.
[84] P. Jordan,et al. Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors , 1999, Oncogene.
[85] Z. Werb,et al. The Significance of Matrix Metalloproteinases during Early Stages of Tumor Progression a , 1998, Annals of the New York Academy of Sciences.
[86] Z. Werb,et al. Matrix Metalloproteinase Stromelysin-1 Triggers a Cascade of Molecular Alterations That Leads to Stable Epithelial-to-Mesenchymal Conversion and a Premalignant Phenotype in Mammary Epithelial Cells , 1997, The Journal of cell biology.
[87] P. Suter,et al. Matrix metalloproteinases and TIMP in acute respiratory distress syndrome. , 1996, American journal of respiratory and critical care medicine.
[88] S. Rosselot. Idiopathic pulmonary fibrosis. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[89] R. Khokha,et al. Tissue inhibitor of metalloproteinases 3 regulates resolution of inflammation following acute lung injury. , 2010, The American journal of pathology.
[90] L. Kruidenier,et al. Myofibroblast matrix metalloproteinases activate the neutrophil chemoattractant CXCL7 from intestinal epithelial cells. , 2006, Gastroenterology.
[91] P. Carmeliet,et al. Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice. , 2005, The American journal of pathology.
[92] Arthur S Slutsky,et al. Ventilator-induced lung injury: from the bench to the bedside , 2005, Intensive Care Medicine.
[93] George Stoica,et al. Expression of MMP2, MMP9 and MMP3 in Breast Cancer Brain Metastasis in a Rat Model , 2005, Clinical & Experimental Metastasis.
[94] Michael J. Green,et al. Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. , 2003, Rheumatology.
[95] J. Mullol,et al. Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.
[96] S. Weiss,et al. Role of stromelysin 1 and gelatinase B in experimental acute lung injury. , 2001, American journal of respiratory cell and molecular biology.
[97] Z. Werb,et al. How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.
[98] B. Boyan,et al. The First Stage of Transforming Growth Factor β1 Activation is Release of the Large Latent Complex from the Extracellular Matrix of Growth Plate Chondrocytes by Matrix Vesicle Stromelysin-1 (MMP-3) , 2001, Calcified Tissue International.